Views & Analysis Rethinking rare diseases: treat the whole patient CRDN wants to break down barriers in communication between rare disease patients, HCPs and industry.
Views & Analysis New business models turn science into market value Delivering better patient benefit and economic returns.
Views & Analysis Clinical trial lay summaries: a clearer picture emerges EC wants pharma to make clinical trial results more patient-friendly.
Views & Analysis Beyond fitness apps: patient-centric mobile health mHealth brings opportunities to better understand how conditions impact everyday life and develop solutions that work.
Views & Analysis Meeting the challenges of rare disease treatment adherence HCPs, pharma and patients can pool their experience to develop effective, tailored support.
Views & Analysis Putting patients as partners The impact of European Patients’ Forum’s campaign for patient empowerment.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
